A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

Exclusion Criteria

• •Incompletely cured pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal
• •Subjects with a medical disorder, condition or history of such that would impair the subject's ability to participate or complete this study in the opinion of the investigator or the sponsor
• •Known hypersensitivity to the study drugs (active substances or excipients of the preparations)
• •Known severe allergies, non-allergic drug reactions, or multiple drug allergies
• •Chronic intestinal disorders associated with distinct disturbances of digestion and absorption
• •States which may deteriorate as a result of increased gas formation in the intestine (e.g. Roemheld´s syndrome, major hernias, intestinal obstructions, intestinal ulcers, Crohn´s disease, ulcerative colitis, malabsorptions)
• •Fasting blood glucose level outside normal range
• •Impaired glucose tolerance in glucose tolerance test